Holding(s) in Company

Released : 04 Oct 2017 09:39

RNS Number : 6759S
Dechra Pharmaceuticals PLC
04 October 2017
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i


1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Dechra Pharmaceuticals PLC

1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)

Non-UK issuer


2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights


An acquisition or disposal of financial instruments


An event changing the breakdown of voting rights

X

Other (please specify)iii:


3. Details of person subject to the notification obligationiv

Name

BlackRock, Inc.

City and country of registered office (if applicable)

Wilmington, DE, USA

4. Full name of shareholder(s) (if different from 3.)v

Name


City and country of registered office (if applicable)


5. Date on which the threshold was crossed or reachedvi:

02/10/2017

6. Date on which issuer notified (DD/MM/YYYY):

03/10/2017

7. Total positions of person(s) subject to the notification obligation


% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

6.79%

0.29%

7.08%

93,404,180

Position of previous notification (if

applicable)

6.82%

0.31%

7.13%


 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type of
shares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB0009633180


6,348,376


6.79%











SUBTOTAL 8. A

6,348,376

6.79%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expiration
date
x

Exercise/
Conversion Period
xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

Securities Lending



136,152

0.14%













SUBTOTAL 8. B 1

136,152

0.14%

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expiration
date
x

Exercise/
Conversion Period
xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

CFD



Cash

136,475

0.14%
















SUBTOTAL 8.B.2

136,475

0.14%

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii


Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity
xiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

See Attachment





10. In case of proxy voting, please identify:

Name of the proxy holder


The number and % of voting rights held


The date until which the voting rights will be held



11. Additional informationxvi

 

BlackRock Regulatory Threshold Reporting Team
 
Timothy Dudley

020 7743 3650

 

 

Place of completion

12 Throgmorton Avenue, London, EC2N 2DL, U.K.

Date of completion

3 October, 2017



 

Section 9 Attachment

 

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

BlackRock, Inc.




BlackRock Holdco 2, Inc.




BlackRock Financial Management, Inc.




BlackRock International Holdings, Inc.




BR Jersey International Holdings L.P.




BlackRock Group Limited




BlackRock Investment Management (UK) Limited








BlackRock, Inc.




BlackRock Holdco 2, Inc.




BlackRock Financial Management, Inc.




BlackRock Holdco 4, LLC




BlackRock Holdco 6, LLC




BlackRock Delaware Holdings Inc.




BlackRock Fund Advisors




BlackRock Institutional Trust Company, National Association








BlackRock, Inc.




BlackRock Holdco 2, Inc.




BlackRock Financial Management, Inc.




BlackRock Holdco 4, LLC




BlackRock Holdco 6, LLC




BlackRock Delaware Holdings Inc.




BlackRock Fund Advisors








BlackRock, Inc.




BlackRock Holdco 2, Inc.




BlackRock Financial Management, Inc.




BlackRock International Holdings, Inc.




BR Jersey International Holdings L.P.




BlackRock Group Limited




BlackRock Advisors (UK) Limited








BlackRock, Inc.




BlackRock Holdco 2, Inc.




BlackRock Financial Management, Inc.




BlackRock International Holdings, Inc.




BR Jersey International Holdings L.P.




BlackRock Holdco 3, LLC




BlackRock Canada Holdings LP




BlackRock Canada Holdings ULC




BlackRock Asset Management Canada Limited








 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLFMMGGRDDGNZG